Rent and real estate tax expense for all facilities for the ninethree months ended December 31,June 30, 2015 and 2014 and 2013 was approximately $94,000,$31,000 respectively, for each period.

MASTER SERVICES AGREEMENT 

On February 12, 2010, ADM agreed to provide certain services to Ivivi Health Sciences, LLC (IHS) pursuant to a Master Services Agreement, as described below:

MANUFACTURING AGREEMENTLEGAL PROCEEDINGS

Under the terms of the February 12, 2010 manufacturing agreement with IHS, ADM has agreed to serve as the exclusive manufacturer of all current and future medical and non-medical electronic and other electronic devices or products to be sold or rented by IHS. For each product that ADM manufactures, IHS pays ADM an amount equal to 120% of the sum of (i) the actual, invoiced cost for raw materials, parts, components or other physical items that are used in the manufacture of product and actually purchased for such entity by ADM, if any, plus (ii) a labor charge the based on ADM’s standard hourly manufacturing labor rate, which ADM believes is more favorable than could be attained from unaffiliated third parties. Under the terms of the Agreement, if ADM is unable to perform its obligations to IHS under the manufacturing agreement or is otherwise in breach of any provision of the manufacturing agreement, IHS has the right, without penalty, to engage third parties to manufacture some or all of its products. In addition, if IHS elects to utilize a third-party manufacturer to supplement the manufacturing being completed by ADM, IHS has the right to require ADM to accept delivery of its products from these third-party manufacturers, finalize the manufacture of the products to the extent necessary to ensure that the design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process have been met.NONE

Pursuant to the manufacturing agreement, sales of finished goods to IHS for the three and nine months ended December 31, 2014 were $-0- and $18,300, respectively.

Sales of finished goods to IHS for the three and nine months ended December 31, 2013 were $9,000 and $46,650, respectively.

LEGAL PROCEEDING

In August 2012, the Company filed a civil suit in the Superior Court of New Jersey against defendants Wellington Scientific LLC (“Wellington”) and Peter F. Lordi, demanding payment of the convertible note receivable from Wellington in the amount of $50,000 (plus accrued interest). The Company is suing for breach of contract, fraud in the inducement, and other claims. Since this civil suit is in the early stages of litigation, its ultimate outcome cannot be predicted with certainty at this time.

Wellington filed a counter claim for unspecified damages which the Company believes is without merit.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our operations and financial condition should be read in conjunction with the condensed consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the "safe harbor" provisions under section 21E of the Securities and Exchange Act of 1934 and the Private Securities Litigation Act of 1995. We use forward-looking statements in our description of our plans and objectives for future operations and assumptions underlying these plans and objectives. Forward-looking terminology includes the words "may", "expects", "believes", "anticipates", "intends", "forecasts", "projects", or similar terms, variations of such terms or the negative of such terms. These forward-looking statements are based on management's current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in such forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this Form 10-Q to reflect any change in our expectations or any changes in events, conditions or circumstances on which any forward-looking statement is based. Factors which could cause such results to differ materially from those described in the forward-looking statements include those set forth under "Item. 1 Description of Business – Risk Factors" and elsewhere in or incorporated by reference into our Annual Report on Form 10-K for the year ended March 31, 2014.2015.

CRITICAL ACCOUNTING POLICIES

CRITICAL ACCOUNTING POLICIES

REVENUE RECOGNITION

We recognize revenue from engineering services on a project or monthly basis and contract manufacturing revenues are recognized after shipment of completed products. For the sale of our electronic products, revenues are recognized when they are shipped to the purchaser.. Shipping and handling charges and costs are de minimis. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in the sales of our electronic products have been de minimis. We have no other post shipment obligations and sales returns have been de minimis.

Revenues from sales of chemical products are recognized when products are shipped to end users.  Shipments to distributors are recognized as sales where no right of return exists.

USE OF ESTIMATES

Our discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to reserves, deferred tax assets and valuation allowance, impairment of long-lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above described items, are reasonable.

BUSINESS OVERVIEW

ADM is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. During the ninethree months ended December 31,June 30, 2015 and 2014, and 2013, our operations are conducted through ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary, Sonotron Medical Systems, Inc. ("SMI"). In addition, the Company owns a minority interest in Montvale Technologies, Inc. (formerly known as Ivivi Technologies, Inc.) ("ITI"), which until October 18, 2006 was operated as a subsidiary of the Company. ITI was deconsolidated as of October 18, 2006 upon the consummation of ITI's initial public offering.

We are a technology-based engineering and manufacturing company with diversified lines of products in the following four areas: (1) electronic products for numerous industries, including therapeutic non-invasive electronic medical devices and electronic controllers for spas and hot tubs, (2) environmentally safe chemical products for industrial use, (3) cosmetic and topical dermatological products and (4) antistatic paint and coatings products.

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED DECEMBER 31, 2014JUNE 30, 2015 AS COMPARED TO DECEMBER 31, 2013JUNE 30, 2014

Revenues were $677,683$1,055,928 for the three months ended December 31, 2014June 30, 2015 as compared to $412,331$623,674 for the three months ended December 31, 2013,June 30, 2014, an increase of $265,352,$432,254, or 64%69%. The increase resulted from an increase in engineering revenue andof $430,450 coupled with an increase in sales to customers in our electronics segmentchemical division of $285,240$68,785 offset by a decrease in our chemicalelectronic segment in the amount of $19,888.$66,981. The increase in engineering services is primarily the result of several projects for one customer.

Gross profit was $393,558,$755,055, or 58.1%71.5%, for the three months ended December 31, 2014June 30, 2015 and $216,544,$285,458, or 52.5%45.8% for the three months ended December 31, 2013. GrossJune 30, 2014. The increase in gross profit percentage increased by 18.4% in ourthe electronics and chemical segments resulted from changes in the mix of products sold. The increase in gross profit in the engineering segment mostlyresulted from better utilization of labor due to an increase in engineering services partially offset with a decrease of 12.8% in our chemical segment.the increased revenue from new projects from one customer.

We are highly dependent upon certain customers to generate our revenues. During the three month period ended December 31, 2014,June 30, 2015, one customer accounted for 45%46% of our revenue. During the three month period ended December 31, 2013, two customersJune 30, 2014, another customer accounted for 23%18% of our revenue. The complete loss of or significant reduction in business from, or a material adverse change in the financial condition of any of our customers could cause a material and adverse change in our revenues and operating results.    

Income from operations for the three months ended December 31, 2014June 30, 2015 was $114,160$434,548 compared to $31,545$35,734 for the three months ended December 31, 2013.June 30, 2014. Selling, general, and administrative expenses increased by $54,241$59,184 or 33%25%, from $164,644$236,037 to $218,885$295,221 mainly due to an increase of $36,608 in legal fees, $13,689$40,383 in royalties and commissions and accounting fees of $16,712.a $17,614 increase in consulting fees.

Interest income decreased $131$726 to $992$321 in the three months ended December 31, 2014,June 30, 2015, from $1,123$1,047 in the three months ended December 31, 2013,June 30, 2014, due to decreased funds invested in a money market account, offset by an increase in accrued interest receivable on a convertible note issued to Wellington.account.

The foregoing resulted in Netnet income for the three months ended December 31, 2014June 30, 2015 of $114,653,$434,228, or $0.00$0.01 per share, compared to net income for the three months ended December 31, 2013June 30, 2014 of $32,537$35,828 or $0.00 per share.

RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED DECEMBER 31, 2014 AS COMPARED TO DECEMBER 31, 2013

Revenues were $2,049,950 for the nine months ended December 31, 2014 as compared to $1,124,742 for the nine months ended December 31, 2013, an increase of $925,208, or 82%. The increase resulted from an increase in sales to customers in both our electronics segment in the amount of $846,890 and chemical segment in the amount of $78,317.

Gross profit was $1,206,909, or 58.9%, for the nine months ended December 31, 2014 and $564,245, or 50.2% for the nine months ended December 31, 2013. Gross profit percentage increased by 25.2% in our electronics segment mostly due to an increase in engineering services partially offset by a decrease of 16.5% in our chemical segment.

We are highly dependent upon certain customers to generate our revenues. During the nine month period ended December 31, 2014, two customer accounted for 34% of our revenue. During the nine month period ended December 31, 2013, two customers accounted for 26% of our revenue. The complete loss of or significant reduction in business from, or a material adverse change in the financial condition of any of our customers could cause a material and adverse change in our revenues and operating results.    

Income from operations for the nine months ended December 31, 2014 was $278,679 compared to a loss from operations for the nine months ended December 31, 2013 of ($89,588). Selling, general and administrative expenses increased by $228,665, or 38%, from $605,712 to $834,377 mainly due to an increase of $46,869 in salaries coupled with an increase in royalties and commissions of $83,968, $26,785 in accounting fees and $46,148 in legal fees.

Interest income decreased $352 to $3,364 in the nine months ended December 31, 2014, from $3,716 in the nine months ended December 31, 2013.

The foregoing resulted in Net income for the nine months ended December 31, 2014 of $279,851, or $0.00 per share, compared to a net loss for the nine months ended December 31, 2013 of ($87,574) or ($0.00) per share.

LIQUIDITY AND CAPITAL RESOURCES

At December 31, 2014,June 30, 2015, we had cash and cash equivalents of $222,799$370,526 as compared to $83,156$216,395 at March 31, 2014.2015. The $139,643$154,131 increase was primarily the result of cash provided in operations during the ninethree month period in the amount of $149,840$161,392 offset by cash used in financing activities in the amount of $9,024$7,000 and cash used in investing activities of $1,173.$261. Our cash will continue to be used for increased marketing costs, and the related administrative expenses, in order to attempt to increase our revenue.  We expect to have enough cash to fund operations for the next twelve months. Our note payable of $127,966$114,966 at December 31, 2014,June 30, 2015, is secured and collateralized by restricted cash of $232,437.$232,786. This note bears an interest rate of 2% above the rate of the savings account. The interest rate at December 31, 2014June 30, 2015 was 2.15% and is payable upon demand.

Future Sources of Liquidity:

We expect that growth in profitable revenues and continued focus on new customers will enable us to continue to generate cash flows from operating activities during fiscal 2015.2016.

If we do not generate sufficient cash from operations, face unanticipated cash needs or do not otherwise have sufficient cash, we may need to consider the sale of certain intellectual property which does not support the Company’s operations. In addition, we have the ability to reduce certain expenses depending on the level of business operation.

Based on current expectations, we believe that our existing cash of $222,799$370,526 as of December 31, 2014June 30, 2015 and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

OPERATING ACTIVITIES 

Net cash provided (used) by operating activities was $149,840$161,392 for the ninethree months ended December 31, 2014,June 30, 2015, as compared to net cash used in operating activities of $(91,019)$(9,262) for the ninethree months ended December 31, 2013.June 30, 2014.  The cash provided during the ninethree months ended December 31, 2014June 30, 2015 was primarily due to net income of $279,851$434,228 and an increasedecreases in operating liabilities of $253,717,$100,349, and a decrease in net operating assets of $390,895.   $173,287.   

INVESTING ACTIVITIES

Cash was used in investing activities in the amount of $1,173 which included$261 from deposits in the restricted cash in the amount of $173 and an investment in Angiodroid of $1,000 for the nine months ended December 31, 2014. The Company made a $1,000 capital contribution in Angiodroid America, Inc. for 20% ownership.

For the nine months ended December 31, 2013, net cash provided by investing activities was $10,138 due to the repayment of a loan to a related party in the amount of $10,620 offset by deposits into the restricted cash account in the amount of $482.$261.

FINANCING ACTIVITIES

For the ninethree months ended December 31,June 30, 2015 and 2014, and 2013, net cash used in financing activities were $9,024$7,000 and $9,000,$4,000, respectively which were repayments on a note from a commercial bank to facilitate our acquisition of AIU.Action Industries Unlimited, Inc. (AIU).

OFF BALANCE SHEET ARRANGEMENTS

We have no off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Concentration of Credit Risk

Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and our investment in ITI. We have no control over the market value of our investment in ITI.

We maintain cash and cash equivalents with FDIC insured financial institutions.

Our sales are materially dependent on a small group of customers, as noted in Note 64 of our condensed consolidated financial statements. We monitor our credit risk associated with our receivables on a routine basis. We also maintain credit controls for evaluating and granting customer credit.

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

The Company's management, including the Company's principal executive officer and principal financial officer, have evaluated the effectiveness of the Company's "disclosure controls and procedures," as such term is defined in Ru1e 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Based upon their evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective for the purpose of ensuring that the information required to be disclosed in the reports that the Company files or submits under the Exchange Act with the Securities and Exchange Commission (the "SEC") (1) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. During the quarterly period ended December 31, 2014,June 30, 2015, there were no changes in the Company's internal control over financial reporting which materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting.

The determination that our disclosure controls and procedures were not effective as of June 30, 2015 are a result of:

a.Deficiencies in Internal Control Structure Environment.The Company experienced net losses for the past several years. During the current year, the Company’s focus was on expanding their customer base to initiate revenue production.  

b.Inadequate staffing and supervision within the accounting operations of our company.The relatively small number of employees who are responsible for accounting functions prevents the Company from segregating duties within its internal control system. The inadequate segregation of duties is a weakness because it could lead to the untimely identification and resolution of accounting and disclosure matters or could lead to a failure to perform timely and effective reviews.  The Company’s plan is to expand its accounting operations as the business of the Company expands.

The Company believes that the financial statements fairly present, in all material respects, the Company’s consolidated balance sheets as of June 30, 2015 and March 31, 2015 and the related statements of operations, stockholders’ equity (deficiency), and cash flows for the three months ended June 30, 2015 and 2014, in conformity with generally accepted accounting principles, notwithstanding the material weaknesses we identified. 

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

In August 2012, the Company filed a civil suit in the Superior Court of New Jersey against defendants Wellington Scientific LLC (“Wellington”) and Peter F. Lordi, demanding payment of the convertible note receivable from Wellington in the amount of $50,000 (plus accrued interest). The Company is suing for breach of contract, fraud in the inducement, and other claims. Since this civil suit is in the early stages of litigation, its ultimate outcome cannot be predicted with certainty at this time.NONE

Wellington filed a counter claim for unspecified damages which the Company believes is without merit.

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended March 31, 2014.2015.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4.MINE SAFETY DISCLOSURES

None

ITEM5. OTHER INFORMATION

None 

ITEM 5.6. EXHIBITS.

(a) Exhibit No.

31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

15